AI-ECG Study for Heart Pathway Localization

This important research study focuses on testing a new artificial intelligence (AI) tool designed to help doctors more accurately locate problematic electrical pathways in the heart. These abnormal pathways, called accessory pathways, can cause irregular heartbeats and may require treatment. The study will compare the AI's ability to identify these pathways against the current gold standard methods used during heart procedures.

The AI technology analyzes standard 12-lead electrocardiograms (ECGs) - the same simple, painless tests that measure heart electrical activity that patients routinely receive. By studying these ECGs, the AI algorithm attempts to pinpoint where these extra electrical pathways are located before the patient undergoes their scheduled heart procedure. During the actual procedure, doctors will use advanced imaging and mapping techniques to identify the true location of these pathways, allowing researchers to check how accurate the AI predictions were.

This research is particularly significant because:

• It could lead to faster, more accurate identification of heart rhythm problems
• The AI tool uses existing ECG technology, making it potentially accessible worldwide
• Better localization could mean shorter, more successful procedures with less radiation exposure
• It may help standardize diagnosis across different hospitals and doctors

The study will enroll about 100 patients aged 13-100 who are already scheduled for an electrophysiology study (a special heart test) because they showed signs of these extra pathways on previous ECGs. Researchers will compare the AI's performance not just against the actual procedure results, but also against human doctors' interpretations of ECGs and against existing manual methods for locating these pathways.

For patients and families, this research represents an exciting step toward more precise heart care. Many people with these electrical pathway problems are otherwise healthy, often young individuals who experience rapid heartbeats. Current methods to locate these pathways require specialized expertise and equipment. An accurate AI tool could help more patients receive proper diagnosis and treatment, especially in areas without specialized heart rhythm specialists.

The potential benefits of this technology extend beyond just this specific heart condition. Success here could pave the way for AI applications in diagnosing other heart rhythm disorders. As healthcare increasingly embraces digital tools, studies like this help ensure these technologies are properly validated before becoming part of routine care. The research team anticipates completing enrollment within 18 months, with final results expected by early 2027.

For patients participating in this study, there are no additional procedures required - the research simply involves analyzing data from tests they would already be receiving as part of their normal care. This makes it a low-risk opportunity to contribute to medical advancement that could help future patients with similar heart conditions.